Loading...

Breast Cancer Cell Lines Exhibit Differential Sensitivities to Microtubule-targeting Drugs Independent of Doubling Time

BACKGROUND: Microtubule-targeting agents (MTAs) are a mainstay in breast cancer treatment, yet patient responses differ. The underlying mechanisms of these differences are unknown. While MTAs are mitotic inhibitors, recent evidence highlights that non-mitotic effects of these drugs can contribute to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Anticancer Res
Main Authors: RISINGER, APRIL L., DYBDAL-HARGREAVES, NICHOLAS F., MOOBERRY, SUSAN L.
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812601/
https://ncbi.nlm.nih.gov/pubmed/26504006
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!